High smoking cessation rate in Crohn's disease patients after physician advice – The TABACROHN Study Tiago Nunes, Maria Josefina Etchevers, Olga Merino,

Slides:

Advertisements

Similar presentations

Volume 109, Issue 1, Pages (January 1996)

Advertisements

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Work disability in inflammatory bowel disease

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008 Peter Laszlo Lakatos,

IBD in the elderly population: Results from a population-based study in Western Hungary, 1977��2008 Peter Laszlo Lakatos, Gyula David, Tunde Pandur,

How do psychological variables influence coping strategies in inflammatory bowel disease? Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel

Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum? Tamás Molnár, Klaudia Farkas, Ferenc.

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody?

Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events Fernando Magro, Manuel.

YouTube® and inflammatory bowel disease

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report Andreia Albuquerque, Fernando Magro,

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature Gurhan.

Volume 140, Issue 2, Pages (August 2011)

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud, Alexander C. Ford,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study Tiago Nunes, Manuel.

A. J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M

Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants T. Felekis, K.H. Katsanos, C.D. Zois,

Serum prohepcidin levels in chronic inflammatory bowel diseases

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Charlotte de Bie, Angelika Kindermann, Johanna Escher

N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Fatal Colonic Perforation in a Pregnant with Behçet's Disease

Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events Fernando Magro, Manuel.

Valle García-Sánchez, Eva Iglesias-Flores, Raúl González, Javier P

Public awareness of Crohn's disease and ulcerative colitis: A national survey Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,

B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek,

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature Dana Duricova, Johan Burisch,

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis Thomas W. Lee, Michael.

Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement Jorge Cuenca, José A. García-Erce, Fernando.

Milagros García, MDa, Ignacio Moneo, MD, PhDb, M

Kinesio Taping reduces disability and pain slightly in chronic non-specific low back pain: a randomised trial Adelaida María Castro-Sánchez, Inmaculada.

M. Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J. L

Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H

The usefulness of factor XIII levels in Crohn's disease

Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients Marko Brinar, Séverine.

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis Niels Teich, Tobias Klugmann Journal of.

Seth Lipka, Seymour Katz, Lev Ginzburg Journal of Crohn's and Colitis

Osteoporosis in inflammatory bowel disease

Volume 148, Issue 4, Pages (April 2015)

Pediatric pulmonary Crohn's disease: More frequent than expected

Ulrich Bonse-Geuking, Michael Kraus Journal of Crohn's and Colitis

Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation Sjoerd F. Bakker,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

Fernando Fernández-Bañares, Antonio Salas, Maria Esteve

Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.

Does active smoking really influence the course of Crohn's disease

Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function Ulf Hindorf, Malin Lindqvist.

Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E

Complete remission of a primary rectal lymphoma on ulcerative colitis, after withdrawal of azathioprine and infliximab Antonio López San Román, Manuel.

Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis S.D. McLaughlin, A. Culkin,

Bowel sonography in occlusive Crohn's disease

The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China Yue Li, Li-fan Zhang, Xiao-qing.

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

National differences in ulcerative colitis experience and management among patients from five European countries and Canada: An online survey Stefan.

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Table of contents The Journal for Nurse Practitioners

Michelle Maria Pietzak Gastroenterology

Table of contents The Journal for Nurse Practitioners

Volume 63, Pages S79-S82 (June 2003)

Presentation transcript:

High smoking cessation rate in Crohn's disease patients after physician advice – The TABACROHN Study Tiago Nunes, Maria Josefina Etchevers, Olga Merino, Sonia Gallego, Valle García-Sánchez, Ignacio Marín-Jiménez, Luis Menchén, Manuel Barreiro-de Acosta, Guillermo Bastida, Sara García, Elena Gento, Daniel Ginard, Eva Martí, Fernando Gomollón, Maite Arroyo, David Monfort, Esther García-Planella, Benito Gonzalez, Carme Loras, Carles Agustí, Carolina Figueroa, Miquel Sans Journal of Crohn's and Colitis Volume 7, Issue 3, Pages 202-207 (April 2013) DOI: 10.1016/j.crohns.2012.04.011 Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 1 Chart flow indicating the population classification according to smoking cessation outcome with number of patients (n) and percentages [%] related to the total population. Journal of Crohn's and Colitis 2013 7, 202-207DOI: (10.1016/j.crohns.2012.04.011) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 2 A) Professionals involved in smoking cessation and B) Pharmacological treatment. GP: general practitioner; ORL: otorhinolaryngologist; GI: gastroenterologist. Journal of Crohn's and Colitis 2013 7, 202-207DOI: (10.1016/j.crohns.2012.04.011) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions